DETECTION OF HUMAN PAPILLOMAVIRUS 16 AND 18 DNA IN CERVICAL DYSPLASIA AND CERVICAL CARCINOMA BY IN SITU HYBRIDIZATION

概要

論文の詳細を見る
We improved the in situ hybridization method using biotinylatyed probes for the detection of human papillomavirus (HPV) 16 and 18 DNA in formalin-fixed and paraffin-embedded tissue sections. Our method included HCl treatment, digestion with 30 μg/ml proteinase K, post-fixation with 70% ethanol and incubation with a streptavidin-biotinylated alkaline phosphatase conjugate for visualization of biotin molecules on DNA probes. The sensitivity of this method using biotinylated DNA probes was comparable to using ^<35>:S labeled RNA probes. Using this method, 72 cases of cervical dysplasia and 51 cases of squamous cell carcinoma of cervix were examined for the presence of HPV 16 and 18 DNA. HPV 16 DNA was detected by in situ hybridization in 19 (26%) cases: 8 of 17 (47%) with milddysplasia, 4 of 24 (16%) with moderate dysplasia and 7 of 30 (23%) with severe dysplasia. In 25 cases of carcinoma in situ and 26 cases of invasive carcinoma, HPV 16 or 18 DNA was detected in 8 cases of which 4 cases had an associated non-malignant lesion. All four cases showed that the intensity in the malignant Iesions was less than the dysplasia or benign lesions in the same patients. These findings suggest that replication of HPV DNA might be suppressed in the transformed cells.
日本組織細胞化学会の論文